… baumannii clinical isolates with resistance to multiple … , was observed at our medical center
in the latter half of 2006. … baumannii clinical isolates identified at our medical center over a …

… the isolate with the biofilm and motility. In this study, we used 60 multidrug resistant clinical
isolates … We first determined the clonal lineage of these isolates and evaluated the synergistic …

… Twenty representative clinical isolates of A. baumannii (referred to below as LAC-1 to LAC-20)
… baumannii clinical isolates were confirmed in our laboratory by using an API 20NE kit …

… baumannii. Time–kill was studied with four multidrug-resistant clinical isolates at … The
PAE was examined after 20 min exposure with five clinical isolates, including the four in …

… baumannii clinical isolates in our hospital are MDR. The remaining therapeutic options for …
baumannii clinical isolates in our hospital are MDR, as it is the case with most Greek hospital …

In this study, we evaluated the existence of classes A, B and D ß-lactamases among
Pseudomonas aeruginosa (P. aeruginosa) and Acinetobacter baumannii (A. baumannii) strains …

… The purpose of this study was undertaken to isolate and identify of A. baumannii from clinical
… baumannii isolates were isolated from blood samples in this study. Hence, 6 (50%) of …

… five isolates with ISAba1 located in the promoter region, but was not detected in an isogenic
imipenem-susceptible A. baumannii isolate … baumannii clinical isolates from Spain, and that …

… baumannii clinical isolates carrying the IS Aba1 , this is inserted into … clinical isolates
belonging to the same pulsetype, one with and one without the IS Aba1 , can be found in the clinical …

Introduction: Acinetobacter baumannii is an important cause of nosocomial infections
worldwide. It is difficult to control, and the infections caused by it are difficult to treat, because it is …